Authors:
MCKINSEY DS
SPIEGEL RA
HUTWAGNER L
STANFORD J
DRIKS MR
BREWER J
GUPTA MR
SMITH DL
OCONNOR MC
DALL L
Citation: Ds. Mckinsey et al., PROSPECTIVE-STUDY OF HISTOPLASMOSIS IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS - INCIDENCE, RISK-FACTORS, AND PATHOPHYSIOLOGY, Clinical infectious diseases, 24(6), 1997, pp. 1195-1203
Citation: Fa. Manian et Ds. Mckinsey, PROSPECTIVE-STUDY OF 2,092 CURBSIDE QUESTIONS ASKED OF 2 INFECTIOUS-DISEASE CONSULTANTS IN PRIVATE-PRACTICE IN THE MIDWEST, Clinical infectious diseases, 22(2), 1996, pp. 303-307
Authors:
KAUFFMAN CA
PAPPAS PG
MCKINSEY DS
GREENFIELD RA
PERFECT JR
CLOUD GA
THOMAS CJ
DISMUKES WE
NEWMAN C
POWDERLY W
SCHELD M
SHARKEYMATHIS PK
CHAPMAN S
HAMILL R
LARSON R
Citation: Ca. Kauffman et al., TREATMENT OF LYMPHOCUTANEOUS AND VISCERAL SPOROTRICHOSIS WITH FLUCONAZOLE, Clinical infectious diseases, 22(1), 1996, pp. 46-50
Citation: Ww. Bohn et al., THE EFFECT OF A PORTABLE HEPA-FILTERED BODY EXHAUST SYSTEM ON AIRBORNE MICROBIAL-CONTAMINATION IN A CONVENTIONAL OPERATING-ROOM, Infection control and hospital epidemiology, 17(7), 1996, pp. 419-422
Authors:
BAMBERGER DR
DRIKS MR
GUPTA MR
OCONNOR MC
JOST PM
NEIHART RE
MCKINSEY DS
MOORE LA
BREWER J
SMITH D
DALL L
STANFORD J
HODGES G
WALLACE J
LEE S
Citation: Dr. Bamberger et al., MYCOBACTERIUM-KANSASII AMONG PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS IN KANSAS-CITY, Clinical infectious diseases, 18(3), 1994, pp. 395-400